AesMed at interCHARM KOREA 2025: A Global Showcase of Hair Loss Solutions

AesMed at interCHARM KOREA 2025: A Global Showcase of Hair Loss Solutions

AesMed successfully participated in interCHARM KOREA 2025, held from July 2–4 at COEX, Seoul.
This exhibition served as a prime opportunity for AesMed to connect with international buyers, dermatology experts, and professionals from leading hair clinics worldwide.

At our Booth A11, AesMed showcased CytoMesopecia, our flagship Cytokines Therapy for Alopecia.
This non-hormonal and scientifically supported treatment continues to gain recognition in Korea and Japan for its ability to effectively restore hair growth and support long-term hair health.

In addition, AesMed introduced AGF39™, the 3rd Evolution Hair Loss Mesotherapy in the History of Alopecia Treatment. AGF39™, powered by seven cytokines, promotes hair follicle regeneration and continues to be a trusted solution for hair loss across Asia.

Another highlight was the presentation of our Hair Care Day Campaign (October 11–November 11), a global initiative designed to raise awareness and build solidarity within the hair loss community.

We are grateful for the meaningful conversations and collaborations that took place at interCHARM KOREA 2025 and look forward to continuing to advance Cytokines Therapy for Alopecia and improve the lives of individuals affected by hair loss.

Stay tuned for more updates on our future initiatives and ongoing commitment to hair restoration.

For more information, please visit: www.aesmed.co.kr